Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hepatitis C, Chronic D019698 12 associated lipids
Coronary Stenosis D023921 6 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Encephalitis D004660 15 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Contracture D003286 3 associated lipids
Stomatitis D013280 14 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Smith SK and Kelly RW Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium. 1988 J. Reprod. Fertil. pmid:3422322
Criscuoli M and Subissi A Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice. 1988 Br. J. Pharmacol. pmid:2894872
Vivier E et al. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression. 1988 Eur. J. Immunol. pmid:2895712
Bourdillat B et al. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. 1988 Eur. J. Pharmacol. pmid:2836213
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Elstad MR et al. Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes. 1988 J. Immunol. pmid:3126231
Hanss M and Dechavanne M 48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. 1988 Thromb. Res. pmid:3126559
Nasmith PE and Grinstein S Cytosolic calcium, oxygen consumption and the intracellular pH of stimulated neutrophils. 1988 Biosci. Rep. pmid:2840131
Dulioust A et al. Immunoregulatory functions of paf-acether. I. Effect of paf-acether on CD4+ cell proliferation. 1988 J. Immunol. pmid:2961808
Acker G et al. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. 1988 Prostaglandins pmid:3129758
Altin JG and Bygrave FL Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. 1988 Biochem. J. pmid:3128268
Bochner BS et al. Adherence of human basophils to cultured umbilical vein endothelial cells. 1988 J. Clin. Invest. pmid:3130394
Crouch MF and Lapetina EG No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. 1988 Biochem. Biophys. Res. Commun. pmid:3132162
Fernandez-Gallardo S et al. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids. 1988 Biochem. J. pmid:2848496
Neuwirth R et al. Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells. 1988 J. Clin. Invest. pmid:3166467
Handley DA et al. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412. 1988 J. Pharmacol. Exp. Ther. pmid:3183958
Shalit M et al. Platelet activating factor increases expression of complement receptors on human neutrophils. 1988 J. Leukoc. Biol. pmid:2842423
Etienne A et al. Role of neutrophils in gastric damage induced by platelet activating factor. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3244384
Ward SG and Westwick J Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. 1988 Br. J. Pharmacol. pmid:3390650
Demopoulos CA et al. Abnormal platelet response to PAF and ADP in beta-thalassaemia. 1988 Int. J. Biochem. pmid:3391336
Rosenthal MD et al. Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells. 1988 Lipids pmid:3148797
Mullane KM et al. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. 1988 Ann. N. Y. Acad. Sci. pmid:2837948
Christman BW et al. Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. 1988 J. Appl. Physiol. pmid:3391901
Sato N et al. Microvascular basis of gastric mucosal protection. 1988 J. Clin. Gastroenterol. pmid:3183337
Goodwin JS and Behrens T Role of lipoxygenase metabolites of arachidonic acid in T cell activation. 1988 Ann. N. Y. Acad. Sci. pmid:2837956
Greenberg S et al. Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. 1988 J. Biol. Chem. pmid:3392016
Etienne A et al. Possible involvement of platelet-activating factor in endotoxin-induced abortion. 1988 Prog. Clin. Biol. Res. pmid:3393560
Abraham WM The role of leukotrienes in allergen-induced late responses in allergic sheep. 1988 Ann. N. Y. Acad. Sci. pmid:2837960
Lazanas M et al. PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs. 1988 Arch. Dermatol. Res. pmid:3395143
Satoh K et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. 1988 Prostaglandins pmid:3399678
Mazière JC et al. PAF-acether decreases low density lipoprotein degradation and alters lipid metabolism in cultured human fibroblasts. 1988 FEBS Lett. pmid:3402608
There is a case for PAF-acether antagonists. Abstracts of the conference. Paris, France, May 25-27, 1988. 1988 Prostaglandins pmid:3399682
Valone FH Platelet-activating factor binding and metabolism during human platelet aggregation. 1988 Thromb. Res. pmid:3400077
Rola-Pleszczynski M PAF in cellular immunology. 1988 Prog Biochem Pharmacol pmid:3043437
Baggiolini M et al. Effects of PAF on neutrophils and mononuclear phagocytes. 1988 Prog Biochem Pharmacol pmid:3043438
Ojima-Uchiyama A et al. Phospholipid analysis of human eosinophils: high levels of alkylacylglycerophosphocholine (PAF precursor). 1988 Lipids pmid:3185116
Skeaff CM and Holub BJ The effect of fish oil consumption on platelet aggregation responses in washed human platelet suspensions. 1988 Thromb. Res. pmid:3187952
Griffin KJ and Levy JV The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF). 1988 Thromb. Res. pmid:3187959
Dawson J et al. Platelet activating factor as a mediator of equine cell locomotion. 1988 Vet. Res. Commun. pmid:3188378
Gay JC and Stitt ES Enhancement of phorbol ester-induced protein kinase activity in human neutrophils by platelet-activating factor. 1988 J. Cell. Physiol. pmid:3192624
Smith LJ et al. Mechanism of platelet activating factor-induced bronchoconstriction in humans. 1988 Am. Rev. Respir. Dis. pmid:3195800
O'Neill C et al. Embryo-derived platelet-activating factor. Its diagnostic and therapeutic future. 1988 Ann. N. Y. Acad. Sci. pmid:3195924
Wasserman SI Platelet-activating factor as a mediator of bronchial asthma. 1988 Hosp. Pract. (Off. Ed.) pmid:3053741
Cunha FQ et al. Failure of PAF-acether to induce in vivo neutrophil migration. 1988 Agents Actions pmid:3055873
Foegh ML Eicosanoids and platelet activating factor mechanisms in organ rejection. 1988 Transplant. Proc. pmid:3059615
Lagarde M Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. 1988 Prog. Lipid Res. pmid:3060881
Pai JK et al. Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. 1988 J. Biol. Chem. pmid:3165977
Rosario-Jansen T et al. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor. 1988 Biochemistry pmid:3167004
Prévost MC et al. Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia. 1988 Biochim. Biophys. Acta pmid:3167085
Nagpurkar A et al. Effect of rat phosphorylcholine-binding protein on platelet aggregation. 1988 Biochim. Biophys. Acta pmid:3167098
Wallace JL Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. 1988 Can. J. Physiol. Pharmacol. pmid:3167675
Armstead WM et al. Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs. 1988 Circ. Res. pmid:3335052
Bonventre JV et al. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. 1988 Am. J. Physiol. pmid:3337246
Wallace JL and Whittle BJ Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone. 1988 Dig. Dis. Sci. pmid:3338370
Benveniste J et al. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. 1988 FEBS Lett. pmid:3338565
Kochanek PM et al. Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats. 1988 J. Cereb. Blood Flow Metab. pmid:3392115
Michel L et al. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. 1988 J. Immunol. pmid:3397536
Steel LK et al. Quantitative, functional and biochemical alterations in the peritoneal cells of mice exposed to whole-body gamma-irradiation. I. Changes in cellular protein, adherence properties and enzymatic activities associated with platelet-activating factor formation and inactivation, and arachidonate metabolism. 1988 Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. pmid:3286551
Barnes PJ et al. Platelet-activating factor as a mediator of allergic disease. 1988 J. Allergy Clin. Immunol. pmid:3286723
Nakayama R and Saito K [PAF and its physiological significance in normal tissue]. 1988 Seikagaku pmid:3286791
Ponpipom MM et al. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. 1988 Biochem. Biophys. Res. Commun. pmid:2829894
Hwang SB Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. 1988 J. Biol. Chem. pmid:2830276
Marquis O et al. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes. 1988 J. Pharmacol. Exp. Ther. pmid:2831350
Domingo MT et al. Presence of specific binding sites for platelet-activating factor (PAF) in brain. 1988 Biochem. Biophys. Res. Commun. pmid:2831903
Dillon PK et al. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action. 1988 Circ. Res. pmid:2832096
Ma YH and Dunham EW Antagonism of the vasodilator effects of a platelet activating factor precursor in anesthetized spontaneously hypertensive rats. 1988 Eur. J. Pharmacol. pmid:2832188
Hellegouarch A et al. Lack of effect of atrial natriuretic factor on the tone induced in rat portal vein by platelet-activating factor. 1988 Eur. J. Pharmacol. pmid:2832190
Valone FH Identification of platelet-activating factor receptors in P388D1 murine macrophages. 1988 J. Immunol. pmid:2832476
Homma H and Hanahan DJ Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. 1988 Arch. Biochem. Biophys. pmid:2833174
Abraham WM and Wanner A Inflammatory mediators of asthma. 1988 Pediatr. Pulmonol. pmid:2455882
Chau LY and Jii YJ Characterization of 3H-labelled platelet activating factor receptor complex solubilized from rabbit platelet membranes. 1988 Biochim. Biophys. Acta pmid:2838093
Thelen M et al. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation. 1988 J. Clin. Invest. pmid:2838524
Terashita Z et al. Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. 1988 Biochem. Pharmacol. pmid:2839198
Prpic V et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. 1988 J. Cell Biol. pmid:2839520
Williams WR et al. Plates and anti-asthma drugs. 1988 Pneumonol Pol pmid:3254508
Kroegel C The potential pathophysiological role of platelet-activating factor in human diseases. 1988 Klin. Wochenschr. pmid:2839728
Archer CB Mediators of heat urticaria. 1988 Clin. Exp. Dermatol. pmid:3256463
Morell GP et al. Paf-acether (platelet-activating factor) and interleukin-1-like cytokine production by lipopolysaccharide-stimulated glomeruli. 1988 Clin. Immunol. Immunopathol. pmid:3257432
Pignol B et al. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection. 1988 Transplant. Proc. pmid:3259039
Bussolino F et al. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. 1988 J. Biol. Chem. pmid:3261295
Schwertschlag US and Whorton AR Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells. 1988 J. Biol. Chem. pmid:3262105
Kosano H and Takatani O Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. 1988 Cancer Res. pmid:3262419
Berstad A et al. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats. 1988 Scand. J. Gastroenterol. pmid:3262915
Morley J et al. Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. 1988 Agents Actions Suppl. pmid:3262989
Stephens LR et al. Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation. 1988 Biochem. J. pmid:2845930
Ukena D and Sybrecht GW [Function of platelet activating factor in asthma]. 1988 Dtsch. Med. Wochenschr. pmid:2846251
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326
Altman R et al. Why single daily dose of aspirin may not prevent platelet aggregation. 1988 Thromb. Res. pmid:3140408
Piper PJ et al. Release of leukotrienes from porcine and human blood vessels by immunological and nonimmunological stimuli. 1988 Ann. N. Y. Acad. Sci. pmid:2837950
Fichelle J et al. Bronchospasmolytic effects of RU 42173. 1988 Fundam Clin Pharmacol pmid:3240917
Misawa M and Takata T [Effects of platelet activating factor on the bronchial musculature and vasculature in dogs]. 1988 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3241511
Yasuda K et al. Acyl type platelet-activating factor in normal rat uterus determined by gas chromatography mass spectrometry. 1988 Biomed. Environ. Mass Spectrom. pmid:3242662
Perico N et al. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney. 1988 Lab. Invest. pmid:3123798
Mallet AI Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives. 1988 Biomed. Environ. Mass Spectrom. pmid:3242671
Suzuki S et al. [Effect of a specific antagonist of platelet-activating factor, FR-900452, on proteinuria and urinary thromboxane excretion in aminonucleoside nephrotic rats]. 1988 Nihon Jinzo Gakkai Shi pmid:3244194
Sueoka K et al. Platelet activating factor-induced early pregnancy factor activity from the perfused rabbit ovary and oviduct. 1988 Am. J. Obstet. Gynecol. pmid:3207134
Stahl GL et al. Detection of platelet-activating factor during traumatic shock. 1988 Circ. Shock pmid:3208421
Haynes J et al. Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs. 1988 J. Appl. Physiol. pmid:3209541
Ryan US et al. Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. 1988 J. Appl. Physiol. pmid:3209566
Rubin RM et al. Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist. 1988 Arch. Ophthalmol. pmid:3261165